NAGAPRASAD NAGAJOTHI M.D. NPI 1780612333

NPI Information

  • NPI: 1780612333
  • Provider Name: NAGAPRASAD NAGAJOTHI, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 7337 CARITAS CIR NW STE 150
    MASSILLON, OH
    ZIP 44646
  • Phone: (330) 478-0001

Map and Directions

Get Directions

NPI Details

Nagaprasad Nagajothi, M.D. is a hematology and oncology internal medicine in Massillon, OH with 29 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Nagaprasad Nagajothi, M.D. NPI is 1780612333. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7337 CARITAS CIR NW STE 150
MASSILLON, OH
ZIP 44646-128
Phone: (330) 478-0001
Fax: (330) 837-2646

The NPI 1780612333 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, azacitidine, 1 mg (HCPCS:J9025)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Vitamin d-3 level (HCPCS:82306)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Blood test, clotting time (HCPCS:85610)
  • Magnesium level (HCPCS:83735)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Anticoagulant management of patient taking warfarin (HCPCS:93793)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Folic acid level, serum (HCPCS:82746)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Stool analysis for blood to screen for colon tumors (HCPCS:82270)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Ringers lactate infusion, up to 1000 cc (HCPCS:J7120)
  • Biopsy of bone marrow (HCPCS:38221)

The enumeration date for this NPI number is 6/30/2006 and was last updated on 12/1/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology35086648OHIOYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
12044639MEDICAIDOHIO
2000000476584OTHEROHIOANTHEM BC/BS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.